The Aflac Cancer & Blood Disorders Center of Children's Healthcare of Atlanta and the Emory University Department of Pediatrics invite applicants for the position of Aflac Hematology Section Chief. The Hematology Program is the largest in the country in clinical volumes, with vigorous laboratory and clinical research in sickle cell disease, hemostasis and thrombosis, as well as general hematology, which encompasses red blood cell disorders and rare anemias, thalassemia, platelet disorders, bone marrow failure, immunohematogy, and vascular anomalies. The Aflac Cancer & Blood Disorders Center provides a rich and collaborative environment for basic, clinical, and translational research and boasts a diverse faculty. In addition, the Aflac Cancer & Blood Disorders Center has close affiliations with research investigators within the Winship Cancer Institute, Emory University, and the Georgia Institute of Technology, and a willingness to collaborate across departmental or center boundaries is essential. The ideal candidate will have a strong record of scientific accomplishments, leadership at the national level, and proven success in obtaining extramural funding to conduct independent research within a defined investigation area related to Hematology.
About the Aflac Cancer & Blood Disorders Center
The successful candidate will join one of the country's most robust pediatric hematology/oncology programs.
• The Aflac Cancer & Blood Disorders Center has 122 faculty and 50 Advance Practice Providers (APPs), conducting basic, translational, and clinical research related to pediatric oncology and hematology disorders, with expertise in leukemias, lymphomas, brain tumors, neuroblastoma, sarcomas, rare tumors, renal tumors, CAR T-cell therapies, hemoglobinopathies, hemophilia and rare blood disorders.
• More than 7,000 children with cancer and blood disorders are treated annually at the Aflac Cancer and Blood Disorders Center.
• The Aflac pediatric hematology program is the largest in the country in terms of annual discharges (PHIS database). We follow over 2,100 active patients with sickle cell disease, and 600 with bleeding or clotting disorders.
• The Hematology Section is comprised of 35 faculty members engaged in clinical care and research.
• The Aflac pediatric oncology program sees ~500 new cancer diagnoses each year. This includes ~150 new solid tumors, ~50 of which are sarcomas. Aflac is the pediatric component of the Winship Cancer Institute of Emory University.
• The Aflac blood and marrow transplantation program performs ~80 transplants each year, and is one of the leaders in curative therapies for hemoglobinopathies.
• In 2022, the Aflac Cancer & Blood Disorders Center was ranked No. 8 in the nation for Pediatric Cancer by US News and World Report and has been in the top 10 since 2020.
• In 2022, Aflac faculty generated $43.3M in extramural funding, including more than $27.7M from the NIH.
• The Aflac fellowship program accepts 6 fellows each year for intensive clinical and research training in pediatric hematology/oncology. We are one of the few pediatric programs with an NIH-funded T32 training grant in non-malignant hematology
• The Aflac Developmental Therapeutics Program offers a wide portfolio of clinical trials from cooperative groups, industry partners, and investigator-initiated studies, and has a larger referral base in the southeastern United States. Aflac is a member of the COG Pediatric Early Phase Clinical Trials Network (PEP-CTN), NANT, TACL, and PBTC.
• Aflac is a leading contributor to the Children's Oncology Group, having been #1 in therapeutic trial enrollments for the past 2 years and annually in the top 4.
This position will allow a wealth of opportunities for research collaborations within the Department of Pediatrics, with Emory's NCI-designated cancer center (Winship Cancer Institute), as well as with Emory basic science departments, the Rollins School of Public Health, the Centers for Disease Control and Prevention, Morehouse School of Medicine, and Georgia Institute of Technology.
Successful candidates will:
• Have an MD and/or PhD degree
• Exhibit a strong record of publications, appropriate funding as an independent investigator, and national leadership in hematology
• Have a history of academic excellence and achievement and of service or leadership in a hematology-oncology program
• Have a strong interest in mentorship of trainees and junior faculty to support growth in research and scholarship
• Work collaboratively to conduct nationally recognized research in pediatric hematology.
• Support the design, execution, and analysis of clinical, translational, and basic science hematology projects.
Salary will be commensurate with experience and accomplishments.
Children's Healthcare of Atlanta and Emory University have worked together since 1956, facilitating leading-edge pediatric research, training, and innovation. Together, our partnership advances research and facilitates evidence-based quality care for children. In 2022, the Emory Department of Pediatrics was the #1 ranked pediatric department in NIH research funding.
To apply
Applicants interested in this position should complete the online application and upload a curriculum vitae, a summary of research accomplishments, a description of future independent research plans, and three letters of reference addressed to:
Douglas K. Graham, MD, PhD
Director, Aflac Cancer & Blood Disorders Center
Children's Healthcare of Atlanta
William G. Woods Professor of Pediatrics
Emory University School of Medicine
2015 Uppergate Dr.
Atlanta, GA 30322
Additional Information
Employment will be in the Emory + Children's Pediatric Institute. The Emory + Children’s Pediatric Institute is an affiliation between Emory University and Children’s Healthcare of Atlanta that is improving the lives of children in Georgia and beyond. The Pediatric Institute combines the unique strengths and resources of each institution in support of our three-part academic missions of providing outstanding clinical care, conducting innovative basic science discovery and clinical research, and coordinating exceptional education of the future healthcare workforce. Our physicians, researchers, and educators have created a model where leadership, commitment and quality are fundamental components of success. Together, we are transforming pediatrics by achieving new levels of clinical excellence—driven by research, teaching and wellness. We look forward to our future together.
Emory University is dedicated to providing equal opportunities and equal access to all individuals regardless of race, color, religion, ethnic or national origin, gender, genetic information, age, disability, sexual orientation, gender identity, gender expression, and veteran's status. Emory University does not discriminate in admissions, educational programs, or employment on the basis of any factor stated above or prohibited under applicable law. Students, faculty, and staff are assured of participation in University programs and in the use of facilities without such discrimination. Emory University complies with Executive Order 11246, as amended, Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veteran's Readjustment Assistance Act, and applicable executive orders, federal and state regulations regarding nondiscrimination, equal opportunity and affirmative action. Emory University is committed to achieving a diverse workforce through application of its affirmative action, equal opportunity and nondiscrimination policy in all aspects of employment including recruitment, hiring, promotions, transfers, discipline, terminations, wage and salary administration, benefits, and training. Inquiries regarding this policy should be directed to the Emory University Department of Equity and Inclusion, 201 Dowman Drive, Administration Building, Atlanta, GA 30322.
Emory University is committed to providing reasonable accommodations to qualified individuals with disabilities upon request. To request this document in an alternate format or to request a reasonable accommodation, please contact the Department of Accessibility Services at 404-727-9877 (V) | 404-712-2049 (TDD). Please note that one week advance notice is preferred.
Software Powered by iCIMS
www.icims.com